MS patients still get drugs to combat relapses and to slow the disease: anti-inflammatory medications (corticosteroids), interferon and interferon-beta, mitoxantrone, natalizumab, an alternative treatment method, such as acupuncture, bee sting, etc. (Mahdavian et al., 2010; Axisa and Hafler, 2016). Here, IFNB1 is linked to myeloid sarcoma.